CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥10,006 | ¥23,505 | ¥33,671 | ¥82,021 |
| - Cash | ¥4,712 | ¥4,321 | ¥4,781 | ¥3,124 |
| + Debt | ¥57 | ¥77 | ¥98 | ¥0 |
| Enterprise Value | ¥5,351 | ¥19,261 | ¥28,987 | ¥78,897 |
| Revenue | ¥3,711 | ¥4,355 | ¥4,511 | ¥4,274 |
| % Growth | -14.8% | -3.4% | 5.5% | – |
| Gross Profit | ¥2,087 | ¥2,417 | ¥3,185 | ¥3,064 |
| % Margin | 56.2% | 55.5% | 70.6% | 71.7% |
| EBITDA | ¥315 | ¥450 | ¥1,306 | ¥1,645 |
| % Margin | 8.5% | 10.3% | 29% | 38.5% |
| Net Income | ¥11 | ¥238 | ¥923 | ¥1,018 |
| % Margin | 0.3% | 5.5% | 20.5% | 23.8% |
| EPS Diluted | 0.54 | 11.96 | 47.93 | 52.98 |
| % Growth | -95.5% | -75% | -9.5% | – |
| Operating Cash Flow | ¥333 | ¥592 | ¥847 | ¥848 |
| Capital Expenditures | -¥43 | -¥540 | -¥359 | -¥99 |
| Free Cash Flow | ¥290 | ¥52 | ¥488 | ¥748 |